Vanderbilt Ingram Cancer Center

For more VICC news, visit their website »

October 31, 2013

VICC debuts new Center for Cancer Targeted Therapies

Vanderbilt-Ingram Cancer Center leaders formally dedicated the space for the new Center for Cancer Targeted Therapies (CCTT), located in the Infusion Center on the second floor of The Vanderbilt Clinic, at a special ribbon-cutting held during last week’s fall meeting of the Cancer Center’s Board of Overseers.

By VUMC News and Communications
October 10, 2013

Concert highlights upcoming cancer survivorship celebration

There are nearly 13 million cancer survivors in the United States thanks to intensive cancer research, improved treatments and cancer support programs. In celebration of cancer survivors and those patients who have passed away from the disease, Vanderbilt-Ingram Cancer Center, in partnership with Gilda’s Club Nashville, will host the 2013 Cancer Survivorship Celebration.

By VUMC News and Communications
October 10, 2013

Probing mutant EGF receptor regulation

Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies.

By Leigh MacMillan
September 26, 2013

Sosman named one of ‘hottest’ researchers in U.S.

Jeffrey Sosman, M.D., professor of Medicine, Ingram Chair for Cancer Research and director of the Vanderbilt Melanoma Program, was named one of the Hottest Scientific Researchers of the last year by Thomas Reuters Science Watch.

By VUMC News and Communications
September 26, 2013

Support group cares for cancer caregivers

Physical fatigue, anxiety and emotional distress are just some of the symptoms that caregivers may experience while undertaking the hard work of helping a friend or loved one cope with cancer.

By VUMC News and Communications
Deciphering DNA code
September 12, 2013

VU study identifies DNA changes in drug-resistant cancer cells

Vanderbilt investigators have combined next-generation sequencing technologies and bioinformatics analyses to screen for genome-wide genetic mutations associated with drug resistance in a series of lung cancer cell lines.

By Leigh MacMillan
August 26, 2013

Tumor factor spurs blood vessel growth

A newly identified factor regulates blood vessel growth in colorectal tumors and could be a promising target for cancer therapies.
By Leigh MacMillan
August 22, 2013

Overcoming resistance in ovarian cancer

The nuclear receptor TR3 contributes to ovarian cancer cell death in response to platinum-based chemotherapy – and may be a good target for overcoming cell resistance to certain treatments.
By Leigh MacMillan
August 1, 2013

‘Undy’ event to raise colon cancer funds, awareness

Vanderbilt will add a new race event, the 2013 Nashville Undy 5000, to the list of affiliated events for the upcoming fall season.
By VUMC News and Communications
June 24, 2013

Predicting cancer’s response to therapy

Researchers are developing imaging methods to predict patient outcome early in the course of chemotherapy for breast cancer – to allow clinicians to adjust therapy for patients who are not responding.
By Leigh MacMillan
June 20, 2013

Maury Regional, VICC to open Spring Hill facility

Maury Regional Medical Center (MRMC) and Vanderbilt-Ingram Cancer Center (VICC) have joined forces to open a new radiation oncology treatment center for cancer patients in Spring Hill, Tenn.
By VUMC News and Communications
June 10, 2013

Factor’s yin-yang tumor effects

A factor produced by most malignant cells can both promote and inhibit tumor growth – an insight that is critical to using cancer drugs developed to block this factor.
By Leigh MacMillan
June 6, 2013

McBride’s fans band together to support cancer research efforts

On Tuesday, award-winning country music star Martina McBride and a group of her fans presented a check for $40,550 in support of cancer research at Vanderbilt-Ingram Cancer Center.
By VUMC News and Communications
1 … 42 43 44 45 46 … 52